Cornea preservation time study: methods and potential impact on the cornea donor pool in the United States

Jonathan H Lass, Loretta B Szczotka-Flynn, Allison R Ayala, Beth A Benetz, Robin L Gal, Anthony J Aldave, Michelle M Corrigan, Steven P Dunn, Ty L McCall, Sudeep Pramanik, George O Rosenwasser, Kevin W Ross, Mark A Terry, David D Verdier, Writing Committee for the Cornea Preservation Time Study Group, Jonathan H Lass, Loretta B Szczotka-Flynn, Allison R Ayala, Beth A Benetz, Robin L Gal, Anthony J Aldave, Michelle M Corrigan, Steven P Dunn, Ty L McCall, Sudeep Pramanik, George O Rosenwasser, Kevin W Ross, Mark A Terry, David D Verdier, Writing Committee for the Cornea Preservation Time Study Group

Abstract

Purpose: The aim of this study was to describe the aims, methods, donor and recipient cohort characteristics, and potential impact of the Cornea Preservation Time Study (CPTS).

Methods: The CPTS is a randomized clinical trial conducted at 40 clinical sites (70 surgeons) designed to assess the effect of donor cornea preservation time (PT) on graft survival 3 years after Descemet stripping automated endothelial keratoplasty (DSAEK). Eyes undergoing surgery for Fuchs endothelial corneal dystrophy or pseudophakic/aphakic corneal edema were randomized to receive donor corneas stored ≤7 days or 8 to 14 days. Donor and patient characteristics, tissue preparation and surgical parameters, recipient and donor corneal stroma clarity, central corneal thickness, intraocular pressure, complications, and a reading center-determined central endothelial cell density were collected. Surveys were conducted to evaluate pre-CPTS PT practices.

Results: The 1330 CPTS donors were: 49% >60 years old, 27% diabetic, had a median eye bank-determined screening endothelial cell density of 2688 cells/mm, and 74% eye bank prepared for DSAEK. A total of 1090 recipients (1330 eyes including 240 bilateral cases) had: median age of 70 years, were 60% female, 90% white, 18% diabetic, 52% phakic, and 94% had Fuchs endothelial corneal dystrophy. Before the CPTS, 19 eye banks provided PT data on 20,852 corneas domestically placed for DSAEK in 2010 to 2011; 96% were preserved ≤7 days. Of 305 American Academy of Ophthalmology members responding to a pre-CPTS survey, 233 (76%) set their maximum PT preference at 8 days or less.

Conclusions: The CPTS will increase understanding of factors related to DSAEK success and, if noninferiority of longer PT is shown, will have great potential to extend the available pool of endothelial keratoplasty donors.Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01537393.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Preservation time for domestic placements used for DSAEK in 2010–2011 via 19 eye banks.

References

    1. Gal RL, Dontchev M, Beck RW, et al. The effect of donor age on corneal transplantation outcome results of the Cornea Donor Study. Ophthalmology. 2008;115:620–626.
    1. Lass JH, Gal RL, Dontchev M, et al. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular Microscopy Ancillary Study results. Ophthalmology. 2008;115:627–632.
    1. Lass JH, Benetz BA, Gal RL, et al. Donor age and factors related to endothelial cell loss 10 years after penetrating keratoplasty: Specular Microscopy Ancillary Study. Ophthalmology. 2013;120:2428–2435.
    1. Mannis MJ, Holland EJ, Gal RL, et al. The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the cornea donor study. Ophthalmology. 2013;120:2419–2427.
    1. Eye Bank Association of America. 2013 Eye Banking Statistical Report. 2014.
    1. Van Meter W, Sheeth PH. Potential adverse effects on the cornea donor pool in 2031. Int J Eye Banking. 2013;1:1–9.
    1. Centers for Disease Control and Prevention. Data Reports. 2014. Available at: . Accessed November 24, 2014.
    1. Sugar A, Gal RL, Beck W, et al. Baseline donor characteristics in the Cornea Donor Study. Cornea. 2005;24:389–396.
    1. Lindstrom RL, Kaufman HE, Skelnik DL, et al. Optisol corneal storage medium. Am J Ophthalmol. 1992;114:345–356.
    1. Walkenbach RJ, Boney F, Ye GS. Corneal function after storage in dexsol or optisol. Invest Ophthalmol Vis Sci. 1992;33:2454–2458.
    1. Lindstrom RL. Advances in corneal preservation. Trans Am Ophthalmol Soc. 1990;88:555–648.
    1. Means TL, Geroski DH, Hadley A, et al. Viability of human corneal endothelium following Optisol-GS storage. Arch Ophthalmol. 1995;113:805–809.
    1. Chang SD, Pecego JG, Zadnik K, et al. Factors influencing graft clarity. Cornea. 1996;15:577–581.
    1. Doganay S, Hepsen IF, Yologlu S, et al. Effect of the preservation-to-surgery interval on corneal allograft survival in low-risk patients. Ophthalmic Surg Lasers Imaging. 2007;38:457–461.
    1. Wagoner MD, Gonnah el-S. Corneal graft survival after prolonged storage in Optisol-GS. Cornea. 2005;24:976–979.
    1. Chen ES, Terry MA, Shamie N, et al. Precut tissue in Descemet's stripping automated endothelial keratoplasty donor characteristics and early postoperative complications. Ophthalmology. 2008;115:497–502.
    1. Guttman C. Donor death-surgery interval may affect DSAEK outcomes. Ophthamology Times. 15April2009.
    1. Price MO, Price FW., Jr Endothelial cell loss after Descemet stripping with endothelial keratoplasty influencing factors and 2-year trend. Ophthalmology. 2008;115:857–865.
    1. Terry MA. Precut tissue for Descemet stripping automated endothelial keratoplasty: complications are from technique, not tissue. Cornea. 2008;27:627–629.
    1. Sugar A, Montoya MM, Beck R, et al. Impact of the Cornea Donor Study on acceptance of corneas from older donors. Cornea. 2012;31:1441–1445.
    1. Eye Bank Association of America. Medical Standards. Washington, DC, 2014.
    1. Louttit MD, Kopplin LJ, Igo RP, Jr, et al. A multicenter study to map genes for Fuchs endothelial corneal dystrophy: baseline characteristics and heritability. Cornea. 2012;31:26–35.
    1. Price MO, Price FW. Descemet's stripping endothelial keratoplasty. Curr Opin Ophthalmol. 2007;18:290–294.
    1. Benetz B, Yee R, Bidros M, et al. Specular Microscopy. In: Krachmer JH, Mannis JJ, Holland E, eds. Cornea: Fundamentals, Diagnosis, Management. 3rd ed St. Louis, MO: Mosby; 2011:177–203.
    1. Benetz BA, Gal RL, Rice C, et al. Dual grading methods by a central reading center for corneal endothelial image quality assessment and cell density determination in the Specular Microscopy Ancillary Study of the Cornea Donor Study. Curr Eye Res. 2006;31:1–9.
    1. Eye Bank Association of America. 2011 Eye Banking Statistical Report. 2012.
    1. Price MO, Fairchild KM, Price DA, et al. Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss. Ophthalmology. 2011;118:725–729.
    1. Kaufman HE, Beuerman RW, Steinemann TL, et al. Optisol corneal storage medium. Arch Ophthalmol. 1991;109:864–868.
    1. Price MO, Knight O, Benetz BA, et al. Randomized, prospective, single-masked clinical trial of endothelial keratoplasty performance with two donor cornea 4° storage solutions and associated chambers. Cornea. 2015;34:253–256.
    1. Sugar J, Montoya M, Dontchev M, et al. Donor risk factors for graft failure in the Cornea Donor Study. Cornea. 2009;28:981–985.
    1. Lass JH, Beck RW, Benetz BA, et al. Baseline factors related to endothelial cell loss following penetrating keratoplasty. Arch Ophthalmol. 2011;129:1149–1154.
    1. Stulting RD, Sugar A, Beck R, et al. Effect of donor and recipient factors on corneal graft rejection. Cornea. 2012;31:1141–1147.
    1. Lass JH, Riddlesworth TD, Gal RL, et al. The effect of donor diabetes history on graft failure and endothelial cell density 10 years after penetrating keratoplasty. Ophthalmology. 2015;122:448–456.
    1. Sugar A, Tanner JP, Dontchev M, et al. Recipient risk factors for graft failure in the cornea donor study. Ophthalmology. 2009;116:1023–1028.
    1. Price MO, Gorovoy M, Price FW, Jr, et al. Descemet's stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology. 2012;120:246–251.
    1. Terry MA, Saad HA, Shamie N, et al. Endothelial keratoplasty: the influence of insertion techniques and incision size on donor endothelial survival. Cornea. 2009;28:24–31.
    1. Terry MA, Shamie N, Chen ES, et al. Endothelial keratoplasty: the influence of preoperative donor endothelial cell densities on dislocation, primary graft failure, and 1-year cell counts. Cornea. 2008;27:1131–1137.
    1. Ang M, Mehta JS, Lim F, et al. Endothelial cell loss and graft survival after Descemet's stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2012;119:2239–2244.
    1. Anshu A, Price MO, Price FW., Jr Descemet stripping automated endothelial keratoplasty for Fuchs endothelial dystrophy-influence of graft diameter on endothelial cell loss. Cornea. 2012;32:5–8.
    1. Elbaz U, Yeung SN, Lichtinger A, et al. EndoGlide versus EndoSerter for the insertion of donor graft in Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2014;158:257–262.
    1. Phillips PM, Phillips LJ, Much JW, et al. Descemet stripping endothelial keratoplasty: six-month results of the first 100 consecutive surgeries performed solo by a surgeon using 1 technique with 100% follow-up. Cornea. 2012;31:1361–1364.
    1. Terry MA, Shamie N, Chen ES, et al. Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure. Ophthalmology. 2009;116:631–639.
    1. Abbott RL, Fine BS, Webster RG, Jr, et al. Specular microscopic and histologic observations in nonguttate corneal endothelial degeneration. Ophthalmology. 1981;88:788–800.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi